Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Precursor Cell Lymphoblastic Leukemia Lymphoma

Known as: ALL, Acute Lymphoid Leukemia, Leukemia, Acute Lymphocytic 
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the… Expand
National Institutes of Health

Related topics

Related topics

27 relations
10 ML Idarubicin Hydrochloride 1 MG/ML InjectionASPARAGINASEAcute lymphocytic leukemiaAggressive natural killer-cell leukemia
Expand

Narrower (1)

Acute lymphoblastic leukemia with lymphomatous features

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Advances in cancer immunotherapy 2019 – latest trends
Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2019
Review
2019
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.
Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment for hematologic malignancies. Two CAR T-cell… Expand
Is this relevant?
Review
2019
Review
2019
Mechanisms of resistance to CAR T cell therapy
  • N. Shah, T. Fry
  • Nature Reviews Clinical Oncology
  • 2019
    • Corpus ID: 71145129
The successes with chimeric antigen receptor (CAR) T cell therapy in early clinical trials involving patients with pre-B cell… Expand
  • figure 1
  • table 1
  • table 2
Is this relevant?
Review
2019
Review
2019
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
Chimeric antigen receptor (CAR) T‐cell therapy represents a major advancement in personalized cancer treatment. In this strategy… Expand
Is this relevant?
Review
2019
Review
2019
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts
Measurable residual disease (MRD) that persists after initial therapy is a powerful predictor of relapse and survival in acute… Expand
Is this relevant?
Review
2018
Review
2018
The Influence of Metabolism on Drug Response in Cancer
Resistance to therapeutic agents, either intrinsic or acquired, is currently a major problem in the treatment of cancers and… Expand
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Review
2018
Review
2018
Clinical use of lentiviral vectors
Viral vectors provide an efficient means for modification of eukaryotic cells, and their use is now commonplace in academic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2018
Review
2018
To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles
Extracellular vesicles (EVs)-based therapeutics are based on the premise that EVs shed by stem cells exert similar therapeutic… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 3
Is this relevant?
Review
2018
Review
2018
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
Purpose of ReviewGenetically engineered T cells expressing a chimeric antigen receptor (CAR-T) targeting specific antigens… Expand
  • table 1
Is this relevant?
Review
2018
Review
2018
CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
T cell chimeric antigen receptor (CAR) technology has allowed for the introduction of a high degree of tumor selectivity into… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE